Nuvaxovid 2024-2025 Formula (Carton)
Not available*
Nuvaxovid Covid-19 Vaccine, Adjuvanted
Product Images NDC 80631-200
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Nuvaxovid Covid-19 Vaccine, Adjuvanted (NDC 80631-200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novavax, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Nuvaxovid 2024-2025 Formula (Syringe Label)
This is a description for an OVID-19 vaccine adjuvanted under the brand name INUVAXOVID. The product details include a lot number (XX0000KKX), expiration date (MM.DD.YYYY), and a data matrix that includes GTIN/LOT/EXP information. The vaccine is produced by Novavax, Inc. and the product code is 0038063 T2000T8.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
